Nucleic Acids in   Switzerland

Exports In 2021, Switzerland exported $2.17B in Nucleic Acids, making it the 4th largest exporter of Nucleic Acids in the world. At the same year, Nucleic Acids was the 17th most exported product in Switzerland. The main destination of Nucleic Acids exports from Switzerland are: Germany ($503M), United States ($393M), Romania ($255M), Belgium ($121M), and China ($98.6M).

The fastest growing export markets for Nucleic Acids of Switzerland between 2020 and 2021 were Germany ($221M), Romania ($126M), and Belgium ($90M).

Imports In 2021, Switzerland imported $932M in Nucleic Acids, becoming the 7th largest importer of Nucleic Acids in the world. At the same year, Nucleic Acids was the 48th most imported product in Switzerland. Switzerland imports Nucleic Acids primarily from: United States ($210M), China ($181M), Ireland ($103M), Belgium ($90M), and Germany ($62.8M).

The fastest growing import markets in Nucleic Acids for Switzerland between 2020 and 2021 were China ($119M), United States ($119M), and Lithuania ($36.5M).

Tariffs In 2019, the average tariff for Switzerland in Nucleic Acids was 0.00074%. The countries with the highest import tariffs for Nucleic Acids were Western Sahara (Most Favoured Nation duty rate treatment, 0.0029%), Mayotte (Most Favoured Nation duty rate treatment, 0.0029%), Reunion (Most Favoured Nation duty rate treatment, 0.0029%), Antarctica (Most Favoured Nation duty rate treatment, 0.0029%), and French South Antarctic Territory (Most Favoured Nation duty rate treatment, 0.0029%).